The clinical pharmacology of fexofenadine in children

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 6 I, 1996, Pages 1062-1064

  Simons, F E R ^a   Bergman, J N ^a   Watson, W T A ^a   Simons, K J ^a  

^a CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FEXOFENADINE; HISTAMINE H1 RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; MALE; PRIORITY JOURNAL; RECEPTOR BLOCKING; SCHOOL CHILD; SKIN TEST; URTICARIA;

EID: 0030471605     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)80192-8     Document Type: Article

References (5)

1. Fexofenadine hydrochloride (MDL 16,455A). Investigational Drug Brochure Edition no. 3 September 1995 Hoechst Marion Roussel, Inc Kansas City (MO)
2. FER Simons WTA Watson KJ Simons Pharmacokinetics and pharmacodynamics of ebastine in children J Pediatr 122 1993 641 646
3. C Lippert J Ling P Brown S Burmaster M Eller L Cheng Mass balance and pharmacokinetics of MDL 16,455A in healthy, male volunteers Pharm Res 12 1995 S-390
4. 1-receptor antagonist drugs N Engl J Med 330 1994 1663 1670
5. RL Woosley Cardiac actions of antihistamines Annu Rev Pharmacol Toxicol 36 1996 233 252